Tackling Underrepresentation to Aid Understanding of Parkinson’s Disease: Progress and Further Opportunities
September 2021
in “
Physiology News
”
Studysummary This abstract contains only graphic design specifications and reports no new research findings.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
The document emphasized the critical need to address underrepresentation in Parkinson's disease (PD) research, particularly among non-European populations, to develop more effective treatments and gain a comprehensive understanding of the disease. It highlighted initiatives like the Global Parkinson's Genetics Program (GP2) and the Latin American Research Consortium on the Genetics of PD (LARGE-PD) aimed at including diverse populations in research. The Physiological Society's commitment to equity, diversity, and inclusion (EDI) through various initiatives, including a D&I taskforce and support funds, was also discussed. The document underscored the importance of sustained investment in research and development (R&D) and the role of inclusivity in scientific progress.
